Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-02 Sale |
2021-11-04 5:41 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,400 | $303.94 | $729,467 | 91,247 (Direct) |
View |
| 2021-10-29 Sale |
2021-11-02 5:07 pm |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,645 | $288.2 | $474,085 | 1,547 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-15 5:46 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
274 | $294.26 | $80,628 | 93,647 (Direct) |
View |
| 2021-09-09 Sale |
2021-09-13 6:24 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $294.75 | $7,368,650 | 214,649 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 4:33 pm |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
3,377 | $285.33 | $963,559 | 33,318 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 4:29 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $283.91 | $982,058 | 93,921 (Direct) |
View |
| 2021-08-30 Sale |
2021-09-02 06:54 am |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,001 | $282.13 | $1,128,802 | 17,354 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 4:42 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
18,956 | $254.18 | $4,818,219 | 93,921 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-05 7:33 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
780 | $250.5 | $195,390 | 971 (Direct) |
View |
| 2021-07-20 Sale |
2021-07-22 8:25 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,585 | $202.09 | $926,605 | 112,877 (Direct) |
View |
| 2021-07-13 Sale(A) |
2021-07-22 6:53 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
1,520 | $202.23 | $307,395 | 117,462 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-15 5:17 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
1,520 | $202.23 | $307,390 | 117,462 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 6:48 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
6,802 | $189.19 | $1,286,870 | 24,801 (Direct) |
View |
| 2021-05-19 Sale |
2021-05-20 9:00 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
22,267 | $171.41 | $3,816,698 | 190,495 (Direct) |
View |
| 2021-05-14 Sale |
2021-05-18 07:52 am |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
445 | $172.25 | $76,651 | 36,695 (Direct) |
View |
| 2021-05-14 Sale |
2021-05-18 07:50 am |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
710 | $172.29 | $122,326 | 24,555 (Direct) |
View |
| 2021-05-14 Sale |
2021-05-18 07:49 am |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
470 | $172.6 | $81,122 | 31,893 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 5:01 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
285 | $176.85 | $50,402 | 115,449 (Direct) |
View |
| 2021-04-06 Sale |
2021-04-08 7:55 pm |
REPLIGEN CORP | RGEN | Bylund James SVP, Global Operations & IT |
360 | $204.25 | $73,530 | 6,324 (Direct) |
View |
| 2021-03-16 Sale |
2021-03-18 9:47 pm |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
1,400 | $196.88 | $275,632 | 37,140 (Direct) |
View |
| 2021-03-12 Sale |
2021-03-12 7:34 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
9,102 | $190.38 | $1,732,847 | 212,762 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 7:33 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
8,000 | $190.44 | $1,523,501 | 31,176 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 9:51 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
21,900 | $190.19 | $4,165,091 | 221,864 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 9:50 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,545 | $192.47 | $682,295 | 32,363 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 9:41 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,075 | $192 | $398,396 | 25,265 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 9:22 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $205 | $205,000 | 1,464 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-10-29 Exercise |
2021-11-02 5:07 pm |
N/A 2030-05-13 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,285 | $0 | 1,547 (Direct) |
View |
| 2021-10-29 Exercise |
2021-11-02 5:07 pm |
N/A N/A |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,285 | $128.18 | 1,547 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 6:24 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $32.4 | 214,649 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 6:24 pm |
N/A 2027-02-23 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $0 | 214,649 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:29 pm |
N/A 2027-05-18 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $0 | 93,921 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:29 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $38.76 | 93,921 (Direct) |
View |
| 2021-08-17 Gift |
2021-08-18 4:16 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
1,000 | $0 | 189,495 (Direct) |
View |
| 2021-07-13 Exercise(A) |
2021-07-22 6:53 pm |
N/A 2025-07-21 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,929 | $0 | 117,462 (Direct) |
View |
| 2021-07-13 Exercise(A) |
2021-07-22 6:53 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,929 | $41.19 | 117,462 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 5:17 pm |
N/A 2025-07-21 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,929 | $0 | 117,462 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 5:17 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,929 | $41.19 | 117,462 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-14 6:48 pm |
N/A 2029-02-28 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
3,602 | $0 | 24,801 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-14 6:48 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,557 | $59.52 | 24,801 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-14 6:48 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
1,045 | $86.1 | 24,801 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:59 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
1,608 | $0 | 1,608 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:57 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
1,608 | $0 | 7,513 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:56 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,608 | $0 | 3,058 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:52 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,608 | $0 | 2,902 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:50 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | Mhatre Rohin Director |
1,608 | $0 | 1,608 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 9:50 pm |
2022-05-13 2031-05-13 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,126 | $0 | 117,575 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:01 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
15,000 | $3.22 | 115,449 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:01 pm |
N/A 2021-12-15 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
15,000 | $0 | 115,449 (Direct) |
View |
| 2021-03-12 Gift |
2021-03-16 9:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
170 | $0 | 1,294 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 7:33 pm |
N/A 2026-12-14 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
8,000 | $0 | 31,176 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 7:33 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
150 | $59.52 | 31,176 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 7:33 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,000 | $33.05 | 31,176 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 7:33 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
5,850 | $33.87 | 31,176 (Direct) |
View |
Ownership |
2021-03-08 7:54 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
0 | $0 | 56,095 (Direct) |
View |
Ownership |
2021-03-08 7:43 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James SVP, Global Operations & IT |
0 | $0 | 18,717 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 9:22 pm |
N/A 2026-05-11 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $0 | 1,464 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 9:22 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $26.12 | 1,464 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 6:11 pm |
N/A 2031-02-24 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
5,320 | $0 | 38,818 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 6:08 pm |
N/A 2031-02-24 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
3,721 | $0 | 29,375 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 6:04 pm |
N/A 2031-02-24 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
23,038 | $0 | 256,365 (Direct) |
View |
| 2020-11-10 Ownership |
2021-02-10 4:01 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
1,000 | $0 | 232,327 (Direct) |
View |